Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Unaudited NAV for May 2023
Unaudited NAV for May 2023
Unaudited NAV for May 2023
eqs_en 
0 09.06.23
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
eqs_en 
0 26.05.23
Correction: Result of Annual General Meeting
Correction: Result of Annual General Meeting
Correction: Result of Annual General Meeting
eqs_en 
0 24.05.23
Result of Annual General Meeting
Result of Annual General Meeting
Result of Annual General Meeting
eqs_en 
0 23.05.23
Portfolio company Ensoma announces closing of Series B Extension
Portfolio company Ensoma announces closing of Series B Extension
Portfolio company Ensoma announces closing of Series B Extension
eqs_en 
0 16.05.23
Unaudited NAV for April 2023
Unaudited NAV for April 2023
Unaudited NAV for April 2023
eqs_en 
0 12.05.23
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
eqs_en 
0 27.04.23
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
eqs_en 
0 25.04.23
Full Year results now to be released on 25 April 2023
Full Year results now to be released on 25 April 2023
Full Year results now to be released on 25 April 2023
eqs_en 
0 19.04.23
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
eqs_en 
0 17.04.23
Unaudited NAV for March 2023
Unaudited NAV for March 2023
Unaudited NAV for March 2023
eqs_en 
0 17.04.23
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation
eqs_en 
0 14.04.23
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
eqs_en 
0 28.03.23
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
eqs_en 
0 21.03.23
Unaudited NAV for February 2023
Unaudited NAV for February 2023
Unaudited NAV for February 2023
eqs_en 
0 16.03.23
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
eqs_en 
0 02.03.23
Portfolio company Disc Medicine announces $62.5 million financing
Portfolio company Disc Medicine announces $62.5 million financing
Portfolio company Disc Medicine announces $62.5 million financing
eqs_en 
0 14.02.23
Unaudited NAV for January 2023
Unaudited NAV for January 2023
Unaudited NAV for January 2023
eqs_en 
0 06.02.23
Unaudited NAV for December 2022
Unaudited NAV for December 2022
Unaudited NAV for December 2022
eqs_en 
0 30.01.23
Board Change
Board Change
Board Change
eqs_en 
0 26.01.23
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
eqs_en 
0 10.01.23
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
eqs_en 
0 05.01.23
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group has successfully closed their €70 Million Series C
eqs_en 
0 02.01.23
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
eqs_en 
0 30.12.22
Unaudited NAV for November 2022
Unaudited NAV for November 2022
Unaudited NAV for November 2022
eqs_en 
0 12.12.22